Market & RegulationInvestment · $2.1B
DeepMind Spinout Isomorphic Labs Raises $2.1B
Siftedhigh confidence
Why it matters
- →Isomorphic Labs is leveraging AI to transform drug discovery, a field traditionally reliant on slower methods.
- →The $2.1 billion funding round indicates strong investor confidence in AI's potential to revolutionize pharmaceuticals.
- →Partnerships with major pharmaceutical companies suggest significant industry interest and potential for impactful collaborations.
Isomorphic Labs, a spinout from DeepMind, has raised $2.1 billion in a Series B funding round led by Thrive Capital. The round also saw participation from the UK’s Sovereign AI fund, Abu Dhabi’s MGX, Alphabet's GV, and Singapore’s Temasek. Founded in 2021, Isomorphic Labs is developing a drug discovery platform using AlphaFold technology to predict protein structures. The company has already partnered with pharmaceutical giants like Eli Lilly and Novartis and is advancing towards pre-clinical trials. This funding highlights the increasing role of AI in transforming drug discovery processes.
Read originalThe story around this
Earlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
More from Sifted
Investment · £540m
Market & Regulationbusiness
Fractile raises £540m Series C
Fractile has secured a massive £540 million Series C, signaling intense capital competition for the UK’s leading AI chip designer. This valuation underscores the strategic pivot toward domestic semiconductor sovereignty in Europe, moving beyond software to hard infrastructure. The funding validates Fractile’s approach to custom silicon for large language models, positioning it as a critical alternative to NVIDIA’s dominance in the European market. Investors are betting heavily on the premise that sovereign AI requires sovereign hardware.
Sifted
Investment · €7.1m
More in Market & Regulation
© TechCrunch AIMarket & Regulationother
Judge allows NAACP lawsuit over xAI pollution to proceed
xAI's attempt to dismiss the NAACP's Clean Air Act lawsuit failed after a federal judge ruled that its gas turbines are not exempt mobile sources and that plaintiffs have standing. This legal setback confirms that AI infrastructure operators cannot bypass environmental permitting by classifying heavy industrial equipment as temporary or mobile. The ruling forces xAI to face scrutiny over air quality impacts at its Colossus data center, setting a precedent for how large-scale compute facilities are regulated under existing environmental laws.
TechCrunch AI
© TechCrunch AI